19.09.2017 | Review Article
Stress Ulcer Prophylaxis in Neurocritical Care
verfasst von:
Jeffrey F. Barletta, Alicia J. Mangram, Joseph F. Sucher, Victor Zach
Erschienen in:
Neurocritical Care
|
Ausgabe 3/2018
Einloggen, um Zugang zu erhalten
Abstract
Stress ulcer prophylaxis (SUP) with acid-suppressive drug therapy is widely utilized in critically ill patients following neurologic injury for the prevention of clinically important stress-related gastrointestinal bleeding (CIB). Data supporting SUP, however, largely originates from studies conducted during an era where practices were vastly different than what is considered routine by today’s standard. This is particularly true in neurocritical care patients. In fact, the routine provision of SUP has been challenged due to an increasing prevalence of adverse drug events with acid-suppressive therapy and the perception that CIB rates are sparse. This narrative review will discuss current controversies with SUP as they apply to neurocritical care patients. Specifically, the pathophysiology, prevalence, and risk factors for CIB along with the comparative efficacy, safety, and cost-effectiveness of acid-suppressive therapy will be described.